<h3>Gainers</h3>
<ul>
<li>Traws Pharma (NASDAQ:TRAW) shares increased by 37.0% to $2.33 during Friday's pre-market session. The market value of their outstanding shares is at $17.2 million. </li>
<li>Amylyx Pharmaceuticals (NASDAQ:AMLX) stock increased by 18.42% to $18.0. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Celldex Therapeutics (NASDAQ:CLDX) stock moved upwards by 12.54% to $37.5. The market value of their outstanding shares is at $2.6 billion. As per the news, the Q1 earnings report came out yesterday. </li>
<li>InMed Pharmaceuticals (NASDAQ:INM) stock rose 12.0% to $0.78. The company's market cap stands at $2.3 million. </li>
<li>Progyny (NASDAQ:PGNY) stock moved upwards by 10.17% to $21.11. The company's market cap stands at $1.6 billion. The company's, Q1 earnings came out yesterday. </li>
<li>Artiva Biotherapeutics (NASDAQ:ARTV) stock increased by 9.82% to $13.75. The company's market cap stands at $307.3 million. As per the news, the Q1 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Sensus Healthcare (NASDAQ:SRTS) shares decreased by 25.1% to $3.08 during Friday's pre-market session. The company's market cap stands at $67.6 million. As per the news, the Q1 earnings report came out yesterday. </li>
<li>Absci (NASDAQ:ABSI) stock decreased by 19.66% to $4.62. The company's market cap stands at $893.8 million. The company's, Q1 earnings came out yesterday. </li>
<li>Amphastar Pharma (NASDAQ:AMPH) shares fell 15.65% to $20.27. The company's market cap stands at $1.0 billion. As per the press release, Q1 earnings came out yesterday. </li>
<li>Capricor Therapeutics (NASDAQ:CAPR) stock decreased by 13.97% to $29.2. The company's market cap stands at $1.9 billion. </li>
<li>Organogenesis Holdings (NASDAQ:ORGO) stock fell 13.84% to $2.18. The company's market cap stands at $320.9 million. The company's, Q1 earnings came out yesterday. </li>
<li>Artivion (NYSE:AORT) shares decreased by 12.5% to $30.99. The company's market cap stands at $1.6 billion. As per the press release, Q1 earnings came out yesterday. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMLX

SRTS

In Friday's pre-market session, Traws Pharma (NASDAQ:TRAW) shares surged 37% to $2.33, while Amylyx Pharmaceuticals (NASDAQ:AMLX) rose 18.42% to $18.0. Other gainers included Celldex Therapeutics (NASDAQ:CLDX) up 12.54% to $37.5, and InMed Pharmaceuticals (NASDAQ:INM) up 12% to $0.78. Conversely, Sensus Healthcare (NASDAQ:SRTS) fell 25.1% to $3.08, Absci (NASDAQ:ABSI) dropped 19.66% to $4.62, and Amphastar Pharma (NASDAQ:AMPH) decreased 15.65% to $20.27. Most companies reported Q1 earnings yesterday.

12 Health Care Stocks Moving In Friday's Pre-Market Session